Publications — Books & chapters

  1. Hurlemann R (2007) The costs and benefits of emotional memory formation. Shaker. ISBN: 978-3832266356

  2. Patin A & Hurlemann R (2015) Chapter 10: Social Cognition. In Kantak KM & Wettstein J (Eds.): Handbook of Experimental Pharmacology, Volume 228, Cognitive Enhancement. Springer. ISBN: 978-3319165219

  3. Patin A & Hurlemann R (2016) Chapter 11: Behavioral consequences and compensatory adaptations after early bilateral amygdala damage in monozygotic twins. In Amaral DG & Adolphs R (Eds.): Living without an amygdala. Guilford Press. ISBN: 978-1462525942

  4. Becker B & Hurlemann R (2016) Chapter 26: Unraveling the role of the amygdala in nicotine addiction. In Preedy RP (Ed.): Neuropathology of Drug Addictions and Substance Misuse, Volume 1, Foundations of Understanding, Tobacco, Alcohol, Cannabinoids, Opioids and Emerging Addiction. Academic Press. ISBN: 978-0128002131

  5. Hurlemann R & Grinevich V (Eds.) (2018) Behavioral Pharmacology of Neuropeptides: Oxytocin. Current Topics in Behavioral Neurosciences, Volume 35. Springer. ISBN: 978-0128002131

  6. Högenauer H & Hurlemann R (2018 & 2021) Kapitel 16: Psychiatrie. In Kraemer A (Ed.): Klinikleitfaden Nachtdienst - Sicher fühlen und kompetent handeln. Urban & Fischer / Elsevier. ISBN: 978-3437222733 (6. Auflage, 2018), 978-3437222740 (7. Auflage, 2021)

  7. Müller C, Spindler M, Kaspers S, Hurlemann R (2022) Chapter 2: Advances in MRI-based anatomy of the human hypothalamus and effects of the hypothalamic neuropeptide oxytocin on brain BOLD signals. In Grinevich V & Dobolyi A (Eds.): Neuroanatomy of Neuroendocrine Systems. Springer. ISBN: 978-3030866297

publications — DGPPN TASKFORCE

Mental Health and Climate Change. Position Statement PDF and Berlin Declaration PDF (articles in German) published by the German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN)

publications — articles

  1. Hammers A, Koepp MJ, Hurlemann R, Thom M, Richardson MP, Brooks DJ, Duncan J (2002) Abnormalities of grey and white matter [(11)C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 125: 2257 - 2271 [IF 7.1] PDF

  2. Hammers A, Koepp MJ, Richardson MP, Hurlemann R, Brooks DJ, Duncan JS (2003) Grey and white matter [(11)C]flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain 126: 1300 - 1318 [IF 8.0] PDF

  3. Strange BA, Hurlemann R, Dolan RJ (2003) Feature article: An emotion-induced retrograde amnesia in humans is amygdala- and beta-adrenergic-dependent. Proceedings of the National Academy of Sciences USA (PNAS) 100: 13626 - 13631 [IF 10.3] PDF Comment in PNAS PDF Evaluated as 'must read' (article factor 8) by Faculty of 1000 Neuroscience 

  4. Strange BA, Hurlemann R, Duggins A, Heinze HJ, Dolan RJ (2005) Dissociating intentional learning from relative novelty responses in the medial temporal lobe. NeuroImage 25: 51 - 62 [IF 5.3] PDF

  5. Herzog H, Tellmann L, Fulton R, Stangier I, Rota-Kops E, Bente K, Boy C, Hurlemann R, Pietrzyk U (2005) Motion artefact reduction in parametric PET images of neuroreceptor binding. Journal of Nuclear Medicine 46: 1059 - 1065 [IF 5.0] PDF

  6. Hurlemann R, Hawellek B, Matusch A, Kolsch H, Wollersen H, Madea B, Vogeley K, Maier W, Dolan RJ (2005) Noradrenergic modulation of emotion-induced forgetting and remembering. The Journal of Neuroscience 25: 6343 - 6349 [IF 7.5] PDF

  7. Hurlemann R, Boy C, Meyer PT, Scherk H, Wagner M, Herzog H, Coenen HH, Vogeley K, Falkai P, Zilles K, Maier W, Bauer A (2005) Decreased prefrontal 5-HT(2A) receptor binding in subjects at enhanced risk for schizophrenia. Anatomy & Embryology (Berl.) 210: 519 - 523 [IF 1.3] PDF

  8. Hurlemann R, Tepest R, Maier W, Falkai P, Vogeley K (2005) Intact hippocampal gray matter in schizophrenia as revealed by automatized image analysis post-mortem. Anatomy & Embryology (Berl.) 210: 513 - 517 [IF 1.3] PDF

  9. Hurlemann R, Matusch A, Eickhoff SB, Palomero-Gallagher N, Meyer PT, Boy C, Maier W, Zilles K, Amunts A, Bauer A (2005) Analysis of neuroreceptor PET data based on cytoarchitectonic maximum probability maps – a feasibility study. Anatomy & Embryology (Berl.) 210: 447 - 453 [IF 1.3] PDF

  10. Hurlemann R (2006) Noradrenergic control of emotion-induced amnesia and hypermnesia. Reviews in the Neurosciences 17: 525 - 532 [IF 3.3] PDF

  11. Dolan RJ, Heinze HJ, Hurlemann R, Hinrichs H (2006) Magnetoencephalography (MEG) determined temporal modulation of visual and auditory sensory processing in the context of classical conditioning to faces. NeuroImage 32: 778 - 789 [IF 5.6] PDF 

  12. Matusch A, Hurlemann R, Rota-Kops E, Winz O, Elmenhorst D, Herzog H, Zilles K, Bauer A (2007) Acute S-ketamine application does not alter cerebral [(18)F]altanserin binding: a pilot PET study in humans. Journal of Neural Transmission 114: 1433 - 1442 [IF 2.7] PDF

  13. Hurlemann R, Wagner M, Hawellek B, Reich H, Pieperhoff P, Amunts K, Oros-Peusquens AM, Shah NJ, Maier W, Dolan RJ (2007) Amygdala control of emotion-induced forgetting and remembering: evidence from Urbach-Wiethe disease. Neuropsychologia 45: 877 - 884 [IF 3.6] PDF

  14. Hurlemann R, Hawellek B, Maier W, Dolan RJ (2007) Enhanced emotion-induced amnesia in borderline personality disorder. Psychological Medicine 37: 971 - 982 [IF 4.2] PDF

  15. Hurlemann R, Matusch A, Klingmuller D, Kolsch H, Maier W, Dolan RJ (2007) Emotion-induced retrograde amnesia varies as a function of noradrenergic-glucocorticoid effects. Psychopharmacology 194: 261 - 269 [IF 3.6] PDF

  16. Hurlemann R, Matusch A, Kuhn KU, Berning J, Elmenhorst D, Winz O, Kolsch H, Zilles K, Wagner M, Maier W, Bauer A (2008) 5-HT(2A) receptor density is decreased in the at-risk mental state. Psychopharmacology 195: 579 - 590 [IF 3.7] PDF Awarded with the Gerd-Huber Prize 2008

  17. Hurlemann R (2008) Noradrenergic-glucococorticoid mechanisms in emotion-induced amnesia: from adaptation to disease. Psychopharmacology 197: 13 - 23 [IF 3.7] PDF

  18. Hurlemann R, Jessen F, Wagner M, Ruhrmann S, Brockhaus A, Picker H, Block W, Scheef L, Schild HH, Moller-Hartmann W, Krug W, Falkai P, Klosterkotter J, Maier W (2008) Interrelated functional and structural evidence of hippocampal pathology in the at-risk mental state. Psychological Medicine 38: 843 - 851 [IF 4.7] PDF

  19. Hurlemann R, Rehme AK, Diessel M, Kukolja J, Maier W, Walter H, Cohen MX (2008) Segregating intra-amygdalar responses to dynamic facial emotion with cytoarchitectonic maximum probability maps. Journal of Neuroscience Methods 172: 13 - 20 [IF 2.1] PDF

  20. Maier W, Mössner R, Quednow BB, Wagner M, Hurlemann R (2008) From genes to psychosis and back: The role of the 5-HT(2A) receptor and prepulse inhibition in schizophrenia. European Archives of Psychiatry & Clinical Neuroscience 258: 40 - 43 [IF 2.9] PDF

  21. Kukolja J, Schlaepfer TE, Keysers C, Klingmuller D, Maier W, Fink GR, Hurlemann R  (2008) Modeling a negative response bias in the human amygdala by noradrenergic–glucocorticoid interactions. The Journal of Neuroscience 28: 12868 - 12876 [IF 7.5] PDF 

  22. Hurlemann R, Schlaepfer TE, Matusch A, Reich H, Shah NJ, Zilles K, Maier W, Bauer A (2009) Reduced 5-HT(2A) receptor signaling following selective bilateral amygdala damage. Social Cognitive & Affective Neuroscience (SCAN) 4: 79 - 84 [IF 4.2] PDF

  23. Onur OA, Walter H, Schlaepfer TE, Rehme AK, Schmidt C, Keysers C, Maier W, Hurlemann R (2009) Noradrenergic enhancement of amygdala responses to fear. Social Cognitive & Affective Neuroscience (SCAN) 4: 119 - 126 [IF 4.2] PDF

  24. Stamelou M, Matusch A, Elmenhorst D, Hurlemann R, Eggert KM, Oertel WH, Zilles K, Höglinger GU, Bauer A (2009) Up-regulation of 5-HT(2A) receptors in the substantia nigra and caudate nucleus in progressive supranuclear palsy correlates with clinical symptom severity. Movement Disorders 24: 1170 - 1175 [IF 4.0] PDF

  25. Goossens L, Kukolja J, Fink GR, Maier W, Griez EJ, Schruers K, Hurlemann R (2009) Selective processing of social stimuli in the superficial amygdala. Human Brain Mapping 30: 3332 - 3338 [IF 6.3] PDF

  26. Bewernick B, Hurlemann R, Matusch A, Kayser S, Hadrysiewics B, Axmacher N, Grubert C, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE (2010) Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistent depression. Biological Psychiatry 67: 110 - 116 [IF 8.7] PDF

  27. Enkel T, Gholizadeh D, von Bohlen und Halbach O, Sanchis-Segura C, Hurlemann R, Spanagel R, Gass P, Vollmayr B (2010) Ambiguous-cue interpretation is biased under stress- and depression-like states in rats. Neuropsychopharmacology 35: 1008 - 1015 [IF 6.7] PDF 

  28. Hurlemann R, Patin A, Onur OA, Cohen MX, Baumgartner T, Metzler S, Dziobek I, Gallinat J, Wagner M, Maier W, Kendrick KM (2010) Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. The Journal of Neuroscience 30: 4999 - 5007 [IF 7.3] PDF Research Highlight: Nature (2010) 464: 1107 PDF 

  29. Hurlemann R & Kendrick KM (2010) The Journal of Neuroscience. Response to Journal Club Feature (published online) [IF 7.3] PDF 

  30. Talmi D, Hurlemann R, Patin A, Dolan RJ (2010) Framing effect following bilateral amygdala lesion. Neuropsychologia 48: 1823 - 1827 [IF 4.0] PDF 

  31. Onur OA, Schlaepfer TE, Kukolja J, Bauer A, Jeung H, Patin A, Otte DM, Shah NJ, Maier W, Kendrick KM, Fink GR, Hurlemann R (2010) The NMDA receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans. Biological Psychiatry 67: 1205 - 1211 [IF 8.7] PDF

  32. Mihov Y, Mayer S, Musshoff F, Maier W, Kendrick KM, Hurlemann R (2010) Facilitation  of learning by social-emotion feedback is beta-noradrenergic-dependent. Neuropsychologia 48: 3168 - 3172 [IF 4.0] PDF

  33. Hurlemann R, Walter H, Rehme AK, Kukolja J, Santoro SC, Schmidt C, Schnell K, Musshoff F, Keysers C, Maier W, Kendrick KM, Onur OA (2010) Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol. Psychological Medicine 27: 1 - 10 [IF 5.2] PDF

  34. Patin A & Hurlemann R (2011) Modulating amygdala responses to emotion: Evidence from pharmacological fMRI. Neuropsychologia 49: 706 - 717 [IF 3.6] PDF

  35. Bach DR, Talmi D, Hurlemann R, Patin A, Dolan RJ (2011) Automatic relevance detection in the absence of a functional amygdala. Neuropsychologia 49: 1302 - 1305 [IF 3.6] PDF

  36. Bechdolf A et al.; PREVENT study group (2011) Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. Schizophrenia Bulletin 37 Suppl 2: S111 - S121 [IF 8.8] Link

  37. Grubert C, Hurlemann R, Bewernick B, Kayser S, Hadrysiewicz B, Axmacher N, Sturm V, Schlaepfer TE (2011) Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression - effects of 12-month stimulation. The World Journal of Biological Psychiatry 12: 516 - 527 [IF 2.4] PDF

  38. Kukolja J, Klingmüller D, Maier W, Fink GR, Hurlemann R (2011) Noradrenergic glucocorticoid modulation of emotional memory encoding in the human hippocampus. Psychological Medicine 4: 1 - 10 [IF 6.2] PDF

  39. Striepens N, Kendrick KM, Maier W, Hurlemann R (2011) Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Frontiers in Neuroendocrinology 32: 426 - 450 [IF 11.4] PDF

  40. Onur OA, Patin A, Mihov Y, Buecher B, Stoffel-Wagner B, Schlaepfer TE, Walter H, Maier  W, Hurlemann R (2012) Feature article: deprivation from smoking disrupts amygdala responses to fear. Human Brain Mapping 33: 1407 - 1416 [IF 6.9] PDF 

  41. Mihov Y, Hurlemann R (2012) Altered amygdala function in nicotine addiction: insights from human neuroimaging studies. Neuropsychologia 50: 1719 - 1729 [IF 3.5] PDF

  42. Becker B, Mihov Y, Scheele D, Kendrick KM, Feinstein JS, Matusch A, Aydin M, Reich H, Urbach H, Oros-Peusquens AM, Shah NJ, Kunz WS, Schlaepfer TE, Zilles K, Maier W, Hurlemann R (2012) Feature article: Fear processing and social networking in the absence of a functional amygdala. Biological Psychiatry 72: 70 - 77 [IF 9.3] PDF 

  43. Scheele D, Mihov Y, Kendrick KM, Feinstein JS, Reich H, Maier W, Hurlemann R (2012) Amygdala lesion profoundly alters altruistic punishment. Biological Psychiatry 72: e5 - e7 [IF 9.3] PDF

  44. Yamasue H, Yee JR, Hurlemann R, Rilling JK, Chen FS, Meyer-Lindenberg A, Tost H (2012) Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. The Journal of Neuroscience 32: 14109 - 14117 [IF 6.9] PDF

  45. Striepens N, Scheele D, Kendrick KM, Becker B, Schaefer L, Schwalba K, Reul J, Maier W, Hurlemann R (2012) Oxytocin facilitates protective responses to aversive social stimuli in males. Proceedings of the National Academy of Sciences USA (PNAS) 109: 18144 - 18149 [IF 9.7] PDF 

  46. Scheele D, Striepens E, Güntürkün O, Deutschländer S, Maier W, Kendrick KM, Hurlemann R (2012) Oxytocin modulates social distance between males and females. The Journal of Neuroscience 32: 16074 - 16079 [IF 6.9; AS 151] PDF Research Highlight: Nature (2012) 492: 157 PDF News Focus: Science (2013) 339: 267 - 269 PDF Society for Neuroscience (SfN) press release PDF 

  47. Helmstaedter C, Mihov Y, Toliat MR, Thiele H, Nürnberg P, Schoch S, Surges R, Elger CE, Kunz WS, Hurlemann R (2013) Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam. Epilepsia 54: 36 - 44 [IF 4.6] PDF Supporting Information PDF Research Highlight: Nature Reviews Neurology (2012) 8: 532 PDF 

  48. Becker B, Scheele D, Moessner R, Maier W, Hurlemann R (2013) Deciphering the neural signature of conversion blindness. The American Journal of Psychiatry 170: 121 - 122 [IF 13.6] PDF

  49. *Feinstein JS, *Buzza C, *Hurlemann R, Dahdaleh NS, Follmer RL, Coryell WH, Welsh MJ, Tranel D, Wemmie JA (2013) Fear and panic in humans with bilateral amygdala damage. Nature Neuroscience 16: 270 - 272 [IF 15.0; AS 243] (*co-lead authors) PDF

  50. Mihov Y, Kendrick KM, Becker B, Zschernack J, Reich H, Maier W, Keysers C, Hurlemann R (2013) Mirroring fear in the absence of a functional amygdala. Biological Psychiatry 73: e9 - e11 [IF 9.5] PDF

  51. Becker B, Klein EM, Striepens E, Mihov Y, Schlaepfer TS, Reul J, Goossens L, Schruers K, Kendrick KM, Hurlemann R (2013) Nicotinic acetylcholine receptors contribute to learning-induced metaplasticity in the hippocampus. Journal of Cognitive Neuroscience 25: 986 - 997 [IF 4.7] PDF

  52. Bach DR, Hurlemann R, Dolan RJ (2013) Unimpaired discrimination of fearful prosody after amygdala lesion. Neuropsychologia 51: 2070 - 2074 [IF 3.5] PDF 

  53. Eckstein M & Hurlemann R (2013) Oxytocin - Evidence for a therapeutic potential of the social neuromodulator. Der Nervenarzt 84: 1321 - 1328 (article in German) [IF 0.9] PDF 

  54. Kayser S, Bewernick BH, Hurlemann R, Soehle M, Schlaepfer TE (2013) Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression. European Neuropsychopharmacology 23: 1541 - 1550 [IF 5.4] PDF

  55. Scheele D, Mihov Y, Schwederski O, Maier W, Hurlemann R (2013) A negative emotional and economic judgment bias in major depression. European Archives of Psychiatry & Clinical Neuroscience 263: 675 - 683 [IF 3.4] PDF

  56. Striepens N, Kendrick KM, Hanking V, Landgraf R, Wuellner U, Maier W, Hurlemann R (2013) Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Scientific Reports 3: 3440 [IF 5.1] PDF

  57. Scheele D, Wille A, Kendrick KM, Stoffel-Wagner B, Becker B, Güntürkün O, Maier W, Hurlemann R (2013) Oxytocin enhances brain reward system responses in men viewing the face of their female partner. Proceedings of the National Academy of Sciences USA (PNAS) 110: 20308 - 20313 [IF 9.8; AS 904] PDF News Focus in Science Link Research Highlight: Nature (2013) 504: 11 PDF 

  58. Becker B, Androsch L, Jahn RT, Alich T, Striepens N, Markett S, Maier W, Hurlemann R (2013) Inferior frontal gyrus preserves working memory and emotional learning under conditions of impaired noradrenergic signaling. Frontiers in Behavioral Neuroscience 7: 197 [IF 4.2] PDF

  59. Striepens N, Matusch A, Kendrick KM, Mihov Y, Elmenhorst D, Becker B, Lang M, Coenen HH, Maier W, *Hurlemann R, Bauer A (2014) Oxytocin enhances attractiveness of unfamiliar female faces independent of the dopamine reward system. Psychoneuroendocrinology 39: 74 - 87 [IF 4.9] (*corresponding author) PDF 

  60. Schlaepfer TE, Bewernick B, Kayser S, Hurlemann R, Coenen VA (2014) Deep brain stimulation of the human reward system for major depression - rationale, outcomes and outlook. Neuropsychopharmacology 39: 1303 - 1314 [IF 7.1] PDF

  61. Preckel K, Scheele D, Kendrick KM, Maier W, Hurlemann R (2014) Oxytocin faciliatates social approach behavior in women. Frontiers in Behavioral Neuroscience 8: 191 [IF 3.3] PDF

  62. Scheele D, Kendrick KM, Khouri C, Kretzer E, Stoffel-Wagner B, Güntürkün O, Maier W, Hurlemann R (2014) An oxytocin-induced facilitation of neural and emotional responses to social touch correlates inversely with autism traits. Neuropsychopharmacology 39: 2078 - 2085 [IF 7.1] PDF

  63. Klein JP, Becker B, Hurlemann R, Scheibe C, Colla M, Heuser I (2014) Effect of specific psychotherapy for chronic depression on neural responses to emotional faces. Journal of Affective Disorders 166: 93 - 97 [IF 3.4] PDF

  64. Eckstein M, Scheele D, Weber K, Stoffel-Wagner B, Maier W, Hurlemann R (2014) Oxytocin facilitates the sensation of social stress. Human Brain Mapping 35: 4741 - 4750 [IF 6.0] PDF

  65. Scheele D, Striepens N, Kendrick KM, Schwering C, Noelle J, Wille A, Schlaepfer TE, Maier W, Hurlemann R (2014) Opposing effects of oxytocin on moral judgment in males and females. Human Brain Mapping 35: 6067 - 6076 [IF 6.0] PDF

  66. Wang S, Xu J, Jiang M, Zhao Q, Hurlemann R, Adolphs R (2014) Autism spectrum disorder, but not amygdala lesions, impairs social attention in visual search. Neuropsychologia 63: 259 - 274 [IF 3.3] PDF

  67. Hurlemann R & Ziemann U (Eds.) (2015) Editorial: Nichtinvasive Hirnstimulation. 
Der Nervenarzt 86: 1479 – 1480 (article in German) [IF 0.8]

  68. Wang S, Tsuchiya N, New J, Hurlemann R, Adolphs R (2015) Preferential attention to animals and people is independent of the amygdala. Social Cognitive & Affective Neuroscience (SCAN) 10: 371 - 380 [IF 5.1] PDF 

  69. Bach DR, Hurlemann R, Dolan RJ (2015) Impaired threat prioritisation after selective bilateral amygdala lesions. Cortex 63: 206 - 213 [IF 4.3] PDF

  70. Polster JD, Kayser S, Bewernick BH, Hurlemann R, Schlaepfer TE (2015) Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval. The Journal of ECT 31: 13 - 19 [IF 1.8] PDF

  71. Hurlemann R, Arndt S, Schlaepfer TE, Reul J, Maier W, Scheele D (2015) Diminished appetitive startle modulation following targeted inhibition of prefrontal cortex. Scientific Reports 5: 8954 [IF 5.2] PDF

  72. Kayser S, Bewernick BH, Matusch A, Hurlemann R, Soehle M, Schlaepfer TE (2015) Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. Psychological Medicine 45: 1073 – 1092 [IF 5.5] PDF

  73. Spunt RP, Elison JT, Dufour N, Hurlemann R, Saxe R, Adolphs R (2015) Amygdala lesions do not compromise the cortical network for false-belief reasoning. Proceedings of the National Academy of Sciences USA (PNAS) 112: 4827 - 4832 [IF 9.4] PDF

  74. Ziegler C, Dannlowski U, Bräuer D, Stevens S, Laeger I, Wittmann H, Kugel H, Dobel C, Hurlemann R, Reif A, Lesch KP, Heindel W, Kirschbaum C, Arolt V, Gerlach A, Hoyer J, Deckert J, Zwanzger P, Domschke K (2015) Oxytocin receptor gene methylation – converging multi-level evidence for a role in social anxiety. Neuropsychopharmacology 40: 1528 - 1538 [IF 6.4] PDF

  75. Hu J, Qi S, Becker B, Luo L, Gao S, Gong Q, Hurlemann R, Kendrick KM (2015) Oxytocin selectively facilitates learning with social feedback and increases activity and functional connectivity in emotional memory and reward processing regions. Human Brain Mapping 36: 2132 - 2146 [IF 5.0] PDF

  76. Kaut O, Schmitt I, Hoffmann A, Hoffmann P, Schlaepfer TE, Wuellner U, Hurlemann R (2015) Abberant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression. European Archives of Psychiatry & Clinical Neuroscience 265:331 - 341 [IF 4.1] PDF

  77. Preckel K, Scheele D, Eckstein M, Maier W, Hurlemann R (2015) The influence of oxytocin on volitional and emotional ambivalence. Social Cognitive & Affective Neuroscience (SCAN) 10: 987 - 993 [IF 5.1] PDF

  78. Becker B, Wagner D, Koester P, Tittgemeyer M, Mercer-Chalmers-Bender K, Hurlemann R, Zhang J, Gouzoulis-Mayfrank E, Kendrick KM, Daumann J (2015) Smaller amygdala and medial prefrontal cortex predict escalating stimulant use. Brain 138: 2074 - 2086 [IF 10.1] PDF

  79. Eckstein M, Becker B, Scheele D, Scholz C, Preckel K, Schlaepfer TE, Grinevich V, Kendrick KM, Maier W, Hurlemann R (2015) Oxytocin facilitates the extinction of conditioned fear in humans. Biological Psychiatry 78: 194 - 202 [IF 11.2] PDF Featured by Scientific American Link Commentary: Biological Psychiatry (2015) 78: 154 - 155 PDF

  80. Harrison L, Hurlemann R, Adolphs R (2015) An enhanced default approach bias following human amygdala lesions. Psychological Science 26: 1543 - 1555 [IF 5.5] PDF

  81. Scheele D, Schwering C, Spunt RP, Elison JT, Maier W, Hurlemann R (2015) A human tendency to anthropomorphize is enhanced by oxytocin. European Neuropsychopharmacology 25: 1817 - 1823 [IF 4.4] PDF

  82. Fürst A, Thron J, Scheele D, Marsh N, Hurlemann R (2015) The neuropeptide oxytocin modulates consumer brand relationships. Scientific Reports 5: 14960 [IF 5.2] PDF

  83. Marsh N, Scheele D, Gerhardt H, Strang S, Enax L, Weber B, Maier W, Hurlemann R (2015) The neuropeptide oxytocin induces a social altruism bias. The Journal of Neuroscience 35: 15696 - 15701 [IF 5.9; AS 188] PDF 

  84. Mielacher C, Scheele D, Hurlemann R (2015) Experimental and therapeutic neuromodulation of emotion and social cognition using non-invasive brain stimulation. Der Nervenarzt 86: 1500 - 1507 (article in German) [IF 0.8] PDF

  85. Hurlemann R & Ziemann U (2015) Non-invasive brain stimulation. Der Nervenarzt 86: 1479 - 1480 (article in German) [IF 0.8] PDF

  86. Hurlemann R, Maier W, Scheele D (2016) Interactions of noradrenaline and cortisol and the induction of indelible memories. Behavioral & Brain Sciences (BBS) 39: e213 [IF 14.2] Link

  87. Hurlemann R & Scheele D (2016) Dissecting the role of oxytocin in the formation and loss of social relationships. Biological Psychiatry 79: 185 - 193 [IF 11.4] PDF

  88. Hu Y, Scheele D, Becker B, Voos G, David B, Hurlemann R, Weber B (2016) The effect of oxytocin on third-party altruistic decisions in unfair situations: an fMRI study. Scientific Reports 6: 20236 [IF 4.3] PDF 

  89. Eckstein M, Scheele D, Patin A, Preckel K, Becker B, Walther A, Domschke K, Grinevich V, Maier W, Hurlemann R (2016) Feature article: Oxytocin facilitates Pavlovian fear learning in males. Neuropsychopharmacology 41: 932 - 939 [IF 6.4] PDF

  90. Khalsa S, Feinstein JS, Li W, Feusner J, Adolphs R, Hurlemann R (2016) Feature article: anxiety in humans with bilateral amygdala lesions: pharmacological induction via cardiorespiratory interoceptive pathways. The Journal of Neuroscience 36: 3559 - 3566 [IF 6.0] PDF Editor's choice PDF

  91. Scheele D, Plota J, Stoffel-Wagner B, Maier W, Hurlemann R (2016) Hormonal contraceptives suppress oxytocin-induced brain reward responses to the partner’s face. Social Cognitive & Affective Neuroscience (SCAN) 11: 767 - 774 [IF 3.9] PDF 

  92. Angermann CE et al.; MOOD-HF study investigators & committee members (2016) Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: The MOOD-HF randomized clinical trial. The Journal of the American Medical Association (JAMA) 315: 2683 - 2693 [IF 44.4] Link

  93. Gao S, Becker B, Luoa L, Genga Y, Zhaoa W, Yina Y, Hua J, Gaoa Z, Gongc Q, Hurlemann R, Yaoa D, Kendrick KM (2016) Oxytocin, the peptide that bonds the sexes also divides them. Proceedings of the National Academy of Sciences USA (PNAS) 113: 7650 - 7654 [IF 9.7] PDF 

  94. Kaut O, Becker B, Schneider C, Zhou F, Fliessbach K, Hurlemann R, Wuellner U (2016) Stochastic resonance therapy induces increased movement-related caudate nucleus activity. Journal of Rehabilitation Medicine 48: 815 - 818 [IF 1.7] PDF

  95. Kasparbauer AM, Meyhoefer I, Steffens M, Weber B, Aydin M, Kumari V, Hurlemann R, Ettinger U (2016) Neural effects of methylphenidate and nicotine during smooth pursuit eye movements. NeuroImage 141: 52 - 59 [IF 5.8] PDF

  96. Hurlemann R & Marsh N (2016) New insights into the neuroscience of human altruism. Der Nervenarzt 87: 1131 - 1135 (article in German) [IF 0.8] PDF

  97. Steffens M, Becker B, Neumann C, Kasparbauer A, Meyhöfer I, Weber B, Mehta M, Hurlemann R, Ettinger U (2016) Effects of ketamine on brain function during smooth pursuit eye movements. Human Brain Mapping 37: 4047 - 4060 [IF 4.5] PDF

  98. Striepens S, Schröter F, Stoffel-Wagner B, Maier W, Hurlemann R, Scheele D (2016) Oxytocin enhances cognitive control of food craving in women. Human Brain Mapping 37: 4276 - 4285 [IF 4.5] PDF

  99. Spengler FB, Becker B, Kendrick KM, Conrad R, Hurlemann R, Schade G (2017) Emotional dysregulation in psychogenic voice loss. Psychotherapy & Psychosomatics 86: 121 - 123 [IF 13.1] PDF

  100. Hurlemann R (2017) Oxytocin-augmented psychotherapy: Beware of context. Neuropsychopharmacology 42: 377 [IF 6.5] PDF

  101. De Cort K, Schroijen M, Hurlemann R, Claassen S, Hoogenhout J, Van den Bergh O, Goossens L, Van Diest I, Schruers K (2017) Modeling the development of panic disorder with interoceptive conditioning. European Neuropsychopharmacology 27: 59 - 69 [IF 4.1] PDF

  102. Hurlemann R, Scheele D, Maier W, Schultz J (2017) Oxytocin drives prosocial biases in favor of attractive people. Behavioral & Brain Sciences (BBS) 40: e30 [IF 15.1] Link 

  103. Hurlemann R, Marsh N, Schultz J, Scheele D (2017) Oxytocin shapes the priorities and neural representations of attitudes and values. Behavioral & Brain Sciences (BBS) 40: e241 [IF 15.1] Link

  104. Strang S, Gerhardt H, Marsh N, Oroz Artigas S, Hu Y, Hurlemann R, Park SQ (2017) A matter of distance - the effect of oxytocin on social discounting is empathy-dependent. Psychoneuroendocrinology 78: 229 - 232 [IF 4.7] PDF

  105. Eckstein M, Markett S, Kendrick KM, Ditzen B, Liu F, Hurlemann R, Becker B (2017) Oxytocin differentially alters resting state functional connectivity between amygdala subregions and emotional control networks: inverse correlation with depressive traits. Neuroimage 149: 458 - 467 [IF 5.4] PDF

  106. Becker B, Steffens M, Zhao Z, Kendrick KM, Neumann C, Weber B, Schultz J, Mehta MA, Ettinger U, Hurlemann R (2017) General and emotion-specific neural effects of ketamine during emotional memory formation. Neuroimage 150: 308 - 317 [IF 5.4] PDF

  107. Wang S, Yu R, Tyszka JM, Zhen S, Kovach C, Sun S, Huang Y, Hurlemann R, Ross IB, Chung J, Mamelak AN, Adolphs R, Rutishauser U (2017) The intensity of specific emotions and their categorical ambiguity in facial expressions are parametrically encoded in the human amygdala. Nature Communications 8:14821 [IF 12.4] PDF

  108. Hurlemann R & Marsh N (2017) Deciphering the modulatory role of oxytocin in human altruism. Reviews in the Neurosciences 28: 335 - 342 [IF 2.6] PDF

  109. Spengler FB, Scheele D, Marsh N, Kofferath C, Flach A, Schwarz S, Stoffel-Wagner B, Maier W, Hurlemann R (2017) Oxytocin facilitates reciprocity in social communication. Social Cognitive & Affective Neuroscience (SCAN) 2: 1325 - 1333 [IF 3.5] PDF

  110. Zimmermann K, Walz C, Derck RT, Kendrick KM, Weber B, Hurlemann R, Becker B (2017) Emotion Regulation Deficits in Regular Marijuana Users. Human Brain Mapping 38: 4270 - 4279 [IF 4.5] PDF

  111. Marsh N, Scheele D, Feinstein JS, Gerhardt H, Strang S, Maier W, Hurlemann R (2017) Oxytocin-enforced norm compliance reduces xenophobic outgroup rejection. Proceedings of the National Academy of Sciences USA (PNAS) 114: 9314 - 9319 [IF 9.5; AS 1018] PDF 

  112. Kaut, Sharma, Schmitt, Hurlemann, Wüllner (2017) DNA methylation of DLG4 and GJA-1 of human hippocampus and prefrontal cortex in major depression is unchanged in comparison to healthy individuals. Journal of Clinical Neuroscience 43: 261 - 263 [IF 1.6] PDF

  113. Kreuder AK, Scheele D, Wassermann L, Wollseifer M, Stoffel-Wagner B, Lee M, Hennig J, Maier W, Hurlemann R (2017) How the brain codes intimacy: The neurobiological substrates of romantic touch. Human Brain Mapping 38: 4525 - 4534 [IF 4.9] PDF

  114. Korn CW, Vunder J, Miro J, Fuentemilla J, Hurlemann R, Bach DR (2017) Amygdala lesions reduce anxiety-like behavior in a human benzodiazepine-sensitive approach-avoidance conflict test. Biological Psychiatry 82: 522 - 531 [IF 12.0] PDF

  115. Spengler FB, Schultz J, Scheele D, Essel M, Maier W, Heinrichs H, Hurlemann R (2017) Kinetics and dose-dependency of intranasal oxytocin effects on amygdala reactivity. Biological Psychiatry 82: 885 - 894 [IF 12.0] PDF Comment in Biological Psychiatry PDF

  116. Patin A, Scheele D, Hurlemann R (2018) Oxytocin and interpersonal relationships.
 Current Topics in Behavioral Neuroscience 35: 389 - 420 [IF n.a.]

  117. Ettinger U, Hurlemann R, Chan RCK (2018) Oxytocin and schizophrenia spectrum disorders.
 Current Topics in Behavioral Neuroscience 35: 515 - 527 [IF n.a.]

  118. Andari E, Hurlemann R, Young LJ (2018) A precision medicine approach to oxytocin trials.
Current Topics in Behavioral Neuroscience 35: 559 - 590 [IF n.a.]

  119. Hurlemann R & Kiebs M (2018) Innovative pharmakologische Strategien für die Behandlung von Angststörungen. 
NeuroTransmitter 29: 32 - 35 (article in German) [IF n.a.]

  120. Wasserthal S, Kloss C, Hurlemann R, Schultz J (2018) N-Acetylcystein (NAC) - eine neue Option zur frühen Bekämpfung von Schizophrenie. 
DNP - Der Neurologe & Psychiater 19: 28 - 32 [IF n.a.]

  121. Schultz J, Wasserthal S, Kloss C, Schmidt S, Ruhrmann S, Hurlemann R (2018) Prävention einer ersten psychotischen Episode. 
Nervenheilkunde 5: 313 - 317 (article in German) [IF n.a.]

  122. Schultz J, Becker B, Preckel K, Seifert M, Mielacher C, Conrad R, Kleiman A, Maier W, Kendrick KM, Hurlemann R (2018) Improving therapy outcome prediction in major depression using multimodal functional neuroimaging - a pilot study. Personalized Medicine in Psychiatry 11 - 12: 7 - 15 [IF n.a.] PDF 

  123. Schultz J & Hurlemann R (2018) Characterizing variations in perceptual decision-making. Behavioral & Brain Sciences (BBS) 41: e241 [IF 17.2] Link

  124. Zimmermann K, Yao S, Heinz M, Zhou F, Dau W, Banger M, Weber B, Hurlemann R, Becker B (2018) Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence. Psychopharmacology 235: 849 - 859 [IF 3.4] PDF

  125. Geng Y, Zhao W, Zhou F, Ma X, Yao S, Hurlemann R, Kendrick KM (2018) Oxytocin enhancement of emotional empathy: generalization across cultures and effects on amygdala activity. Frontiers in Behavioral Neuroscience 12: 512 [IF 2.6] PDF

  126. Lendvai IS, Maier A, Scheele D, Hurlemann R, Kinfe TM (2018) Spotlight on cervical vagus nerve stimulation in patients with primary headache disorders: A Review. Journal of Pain Research 11: 1613 - 1625 [IF 2.2] PDF

  127. Steffens M, Neumann C, Kasparbauer A.-M, Becker B., Weber B, Mehta M.A, Hurlemann R, Ettinger U (2018) Effects of ketamine on brain function during response inhibition. Psychopharmacology 235: 3559 - 3571 [IF 3.4] PDF

  128. Kinfe TM & Hurlemann R (2018) Is molecular inflammatory profiling a useful tool for personalized brain stimulation in psychiatric disorders? Neuromodulation: Technology at the Neural Interface 21: 826 - 827 [IF 2.1] PDF

  129. Zhou F, Zimmermann K, Xin F, Scheele D, Dau W, Banger M, Weber B, Hurlemann R, Kendrick KM, Becker B (2018) Shifted balance of dorsal versus ventral striatal communication with frontal reward and regulatory regions in cannabis dependent males. Human Brain Mapping 39: 5062 - 5073 [IF 4.6] PDF

  130. Hurlemann R, Scheele D, Kinfe TM, Berger R, Philipsen A, Voncken M, Kuypers KPC, Schruers K (2019) Increased temporal discounting in social anxiety disorder normalizes after oxytocin treatment. Psychotherapy & Psychosomatics 88: 55 - 57 [IF 14.9] PDF

  131. Scheele D, Lieberz J, Patin A, Engels C, Schneider L, Stoffel-Wagner B, Becker B, Hurlemann R (2019) Trauma disclosure moderates the effects of oxytocin on intrusions and neural responses to fear. Psychotherapy & Psychosomatics 88: 61 - 63 [IF 14.9] PDF 

  132. Maier A, Scheele D, Spengler F, Menba T, Mohr F, Güntürkün O, Stoffel-Wagner B, Kinfe T, Maier W, Khalsa S, Hurlemann R (2019) Oxytocin reduces a chemosensory-induced stress bias in social perception. Neuropsychopharmacology 44: 281 - 288 [IF 6.8] PDF

  133. Gravius N, Chaudhry SR, Muhammad S, Boström A, Gravius S, Randau T, Scheele D, Westhofen P, Kruppenbacher J, Stoffel-Wagner B, Maier C, Weidlich A, Yearwood TL, Chakravarthy KV, Kramer JM, Hurlemann R, Kinfe TM (2019) Selective L4 dorsal root ganglion stimulation evokes pain relief and changes of inflammatory markers: Profiling of saliva and serum molecular patterns. Neuromodulation: Technology at the Neural Interface 22: 44 - 52 [IF 4.0] PDF

  134. Kinfe TM & Hurlemann R (2019) Non-invasive and invasive brain stimulation concepts for the targeted treatment of schizophrenia symptom domains. Der Nervenarzt 90: 73 - 88 (article in German) [IF 0.8] PDF

  135. Kreuder AK, Wassermann L, Wollseifer M, Ditzen B, Eckstein M, Stoffel-Wagner B, Hennig J, Hurlemann R, Scheele D (2019) Oxytocin enhances the pain-relieving effects of social support in romantic couples. Human Brain Mapping 40: 242 - 251 [IF 4.4] PDF

  136. Lefevre A, Hurlemann R, Grinevich V (2019) Imaging neuropeptide effects on human brain function. Cell & Tissue Research (CTR) 375: 279 - 286 [IF 4.0] PDF

  137. Chaudhry SR, Lendvai IS, Muhammad S, Westhofen P, Kruppenbacher J, Scheef L, Boecker H, Scheele D, Hurlemann R, Kinfe TM (2019) Interictal assay of peripheral circulating inflammatory mediators in migraine patients under adjunctive cervical non-invasive vagus nerve stimulation: a proof-of-concept study. Brain Stimulation 12: 643 - 651 [IF 6.6] PDF

  138. Eckstein M, Almeida de Minas AC, Scheele D, Kreuder AK, Hurlemann R, Grinevich V, Ditzen B (2019) Oxytocin for learning calm and safety. International Journal of Psychophysiology 136: 5 - 14 [IF 2.6] PDF

  139. Kiebs M, Hurlemann R, Mutz J (2019) Cognitive effects of non-surgical brain stimulation for major depressive disorder: Protocol for a systematic review and meta-analysis. BMJ Open 9: e023796 [IF 2.5] PDF

  140. Boström A, Scheele D, Stoffel-Wagner B, Hönig F, Chaudhry SR, Muhammad S, Hurlemann R, Krauss JK, Lendvai IS, Chakravarthy KV, Kinfe TM (2019) Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study. Journal of Translational Medicine 17: 53 [IF 4.1] PDF

  141. Luckhaus C, Juckel G, Hurlemann R (2018) Oxytocin in schizophrenia: Evidence for an etiological and therapeutic relevance of the social neuromodulator. Der Nervenarzt 90: 277 - 284 (article in German) [IF 0.8] PDF

  142. Zimmermann K, Kendrick KM., Scheele D, Dau W, Banger M, Maier W, Weber B, Ma Y, Hurlemann R, Becker B (2019) Altered striatal reward processing in abstinent dependent cannabis users: social context matters. European Neuropsychopharmacology 29: 356 - 364 [3.9] PDF

  143. Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH (2019) Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ - British Medical Journal 364: l1079 [IF 30.2] PDF

  144. Chakravarthy K, Xing F, Bruno K, Kent AR, Raza A, Hurlemann R, Kinfe TM (2019) A review of spinal and peripheral nneuromodulation and neuroinflammation: Lessons learned thus far and future prospects of biotype development. Neuromodulation: Technology at the Neural Interface 22: 235 - 243 [IF 4.0] PDF

  145. Waytz A, Cacioppo JT, Hurlemann R, Castelli F, Adolphs R, Paul LK (2019) Anthropomorphizing without social cues requires the basolateral amygdala. Journal of Cognitive Neuroscience 31: 482 - 496 [IF 3.1] PDF

  146. Spengler FB, Scheele D, Kaiser S, Heinrichs M. Hurlemann R (2019) A protective mechanism against illusory perceptions is amygdala-dependent. The Journal of Neuroscience 39: 3301 - 3308 [IF 5.7] PDF

  147. Coenen V, Bewernick B, Kayser S, Kilian H, Boström J, Greschus S, Hurlemann R, Klein M, Spanier S, Sajonz B, Urbach H, Schlaepfer TE (2019) Superolateral medial forebrain bundle deep brain stimulation in major depression – a gateway trial. Neuropsychopharmacology 44: 1224 - 1232 [IF 6.8] PDF

  148. Kinfe TM, Asif M, Chakravarthy KV, Deer TR, Kramer JM, Yearwood TL, Hurlemann R, Hussain MS, Motameny S, Wagle P, Nürnberg P, Gravius S, Randau T, Gravius N, Chaudhry SR, Muhammad S (2019) Unilateral L4-dorsal root ganglion stimulation evokes pain relief in chronic neuropathic postsurgical knee pain and changes of inflammatory markers: part II whole transcriptome profiling. Journal of Translational Medicine 17: 205 [IF 4.1] PDF

  149. Hasan MT, Althammer F, Silva da Gouveia M, Goyon S, Eliava M, Lefevre A, Kerspern D, Schimmer J, Raftogianni A, Wahis J, Knobloch-Bollmann HS, Tang Y, Liu X, Jain A,  Chavant V, Goumon Y, Weislogel J-M, Hurlemann R, Herpertz SC, Pitzer C, Darbon P, Dogbevia GK, Bertocchi I, Larkum ME, Sprengel R, Bading H, Charlet A, Grinevich V (2019) A fear memory engram and its plasticity in the hypothalamic oxytocin system. Neuron 103: 133 - 146 [IF 14.4] PDF

  150. Schultz J, Willems T, Gädeke M, Chakkour G, Franke A, Weber B, Hurlemann R (2019) A human subcortical network underlying social avoidance revealed by risky economic choices. eLife 8: e45249 [IF 7.1] PDF

  151. Kiebs M, Hurlemann R, Fu CHY, Mutz J (2019) rTMS in non-treatment-resistant depression. The British Journal of Psychiatry 215: 445 - 446 [IF 7.9] PDF

  152. Zhou X, Zimmermann K, Xin F, Zhao W, Derckx R, Sassmannshausen A, Scheele D, Hurlemann R, Weber B, Kendrick KM, Becker B (2019) Cue-reactivity in the ventral striatum characterizes heavy cannabis use, whereas reactivity in the dorsal striatum mediates dependent use. Biological Psychiatry: Cognitive Neuroscience & Neuroimaging 4: 751 - 762 [IF 5.3] PDF

  153. Hurlemann R & Marsh N (2019) Unraveling the role of oxytocin in the motivational structure of conflict. Behavioral & Brain Sciences (BBS) 42: e126 [IF 17.3] Link

  154. Kinfe TM, Buchfelder M, Chaudhry SR, Chakravarthy KV, Deer TR, Russo M, Georgius P, Hurlemann R, Rasheed M, Muhammad S, Yearwood TL. Leptin and associated mediators of immunometabolic signaling: Novel molecular outcome measures for neurostimulation to treat chronic pain. International Journal of Molecular Sciences 20: 4737 [IF 4.6] PDF

  155. Bach DR, Hoffmann M, Finke C, Hurlemann R, Ploner C (2019) Disentangling hippocampal and amygdala contribution to human anxiety-like behavior. The Journal of Neuroscience 39: 8517 - 8526 [IF 5.7] PDF

  156. Lardenoije R, Roubroeks JAY, Pishva E, Leber M, Wagner H, Iatrou A, Smith AR, Smith RG, Eijssen LMT, Kleineidam L, Kawalia A, Hoffmann P, Luck T, Riedel-Heller S, Jessen F, Maier W, Wagner M, Hurlemann R, Kenis G, Ali M, Del Sol A, Mastroeni D, Delvaux E, Coleman PD, Mill J, Rutten BPF, Lunnon K, Ramirez A, van den Hove DLA (2019) Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood. Clinical Epigenetics 11: 164 [IF 5.0] PDF

  157. Schmidt S, Hurlemann R, Schultz J, Wasserthal S, Kloss C, Maier W, Meyer-Lindenberg A, Hellmich M, Muthesius-Digon A, Wiesner PS, Klosterkötter J, Ruhrmann S (2019) Multimodal prevention of first psychotic episode through N-acetyl-L-cysteine and Integrated Preventive Psychological Intervention in individuals clinically at high risk for psychosis. Protocol of a randomised, placebo-controlled, parallel-group trial. Early Intervention in Psychiatry 13: 1404 - 1415 [IF 2.3] PDF

  158. Scheele D, Zimbal S, Feinstein JS, Delis A, Neumann C, Mielacher C, Philipsen A, Hurlemann R (2019) Treatment-resistant depression and ketamine response in a patient with bilateral amygdala damage. The American Journal of Psychiatry 176: 982 - 986 [IF 14.1] PDF

  159. Kiebs M, Hurlemann R, Mielacher C (2020) Repetitive transkranielle Magnetstimulation in der Depressionsbehandlung. 
Internistische Praxis 63: 120 - 129 [IF n.a.] 
Reprints (2021) in: Tägliche Praxis 64: 497 - 506 & Paediatrische Praxis 96: 265 - 274 (articles in German) [IF n.a.]

  160. Maier AM, Gieling C, Heinen-Ludwig L, Stefan V, Schultz J, Güntürkün O, Stoffel-Wagner B, Becker B, Hurlemann R, Scheele D (2020) Association of childhood maltreatment with interpersonal distance and social touch preferences in adulthood. The American Journal of Psychiatry 177: 37 - 46 [IF 18.1] PDF

  161. Zhao W, Zimmermann K, Zhou X, Zhou F, Fu M, Dernbach C, Scheele D, Weber B, Eckstein M, Hurlemann R, Kendrick KM, Becker B (2020) Impaired cognitive performance under psychosocial stress in cannabis-dependent men is associated with attenuated precuneus activity. Journal of Psychiatry & Neuroscience 44: 1 - 10 [IF 6.2] PDF

  162. Lieberz J, Scheele D, Spengler FB, Matheisen T, Schneider L, Stoffel-Wagner B, Kinfe TM, Hurlemann R (2020) Kinetics of oxytocin effects on amygdala and striatal reactivity vary between women and men. Neuropsychopharmacology 45: 1134 - 1140 [IF 7.9] PDF

  163. Kaut O, Mielacher C, Hurlemann R, Wüllner U (2020) Resting-state fMRI reveals increased functional connectivity in the cerebellum but decreased functional connectivity of the caudate nucleus in Parkinson's disease. Neurological Research 42: 62 - 67 [IF 2.5] PDF

  164. Kreuder AK, Scheele D, Schultz J, Hennig J, Marsh N, Dellert T, Ettinger U, Philipsen A, Babasiz M, Herscheid A, Remmersmann L, Stirnberg R, Stöcker T, Hurlemann R (2020) Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear – A randomized clinical trial. Proceedings of the National Academy of Sciences USA (PNAS) 117: 11781 - 11787 [IF 11.2] PDF

  165. Kinfe TM, Stadlbauer A, Winder K, Hurlemann R, Buchfelder M (2020) Incisionless MR-guided focused ultrasound: Technical considerations and current therapeutic approaches in psychiatric disorders. Expert Review of Neurotherapeutics 20: 687 - 696 [IF 4.6] PDF

  166. Lippold JV, Ettinger U, Hurlemann R, Corr PJ, Reuter M, Perkins AM (2020) Differentiating anxiety from fear: An experimental-pharmacological approach.
 Personality Neuroscience 3: e6 [IF n.a.] PDF

  167. Maier A, Heinen-Ludwig L, Güntürkün O, Hurlemann R, Scheele D (2020) Childhood maltreatment alters the neural processing of chemosensory stress signals. Frontiers in Psychiatry 11: 783 [IF 4.2] PDF

  168. Mielacher C, Schultz J, Kiebs M, Dellert T, Metzner A, Graute L, Högenauer H, Maier W, Lamm C, Hurlemann R (2020) Individualized theta-burst stimulation modulates hippocampal activity and connectivity in patients with major depressive disorder. Personalized Medicine in Psychiatry 23: 100066 [IF n.a.] PDF

  169. Grobe-Einsler M, Vogt IR, Schaprian T, Hurlemann R, Klockgether T, Kaut O (2020) Effects of rivastigmine in patients with spinocerebellar ataxia type 3 (SCA3) - a case series of five patients. Neurodegenerative Diseases 20: 104 - 109 [IF 3.0] PDF

  170. Marsh N, Marsh AA, Lee MR, Hurlemann R (2021) Oxytocin and the neurobiology of prosocial behavior. The Neuroscientist 27: 604 - 619 [IF 7.2] PDF

  171. Gellner AK, Voelter J, Schmidt U, Beins EC, Stein V, Philipsen A, Hurlemann R (2021) Molecular and neurocircuitry mechanisms of social avoidance. Cellular & Molecular Life Sciences (CMLS) 78: 1163 - 1189 [IF 9.2] PDF

  172. Bey K, Lippold JV, Aslan B, Hurlemann R, Ettinger U (2021) Effects of lorazepam on prosaccades and saccadic adaptation. Journal of Psychopharmacology 35: 91 - 99 [IF 4.6] PDF

  173. Marvar P, Andero-Gali R, Hurlemann R, Lago TR, Zelikowsky M, Dabrowska J (2021) Limbic neuropeptidergic modulators of emotion and their therapeutic potential for anxiety and post-traumatic stress disorder. The Journal of Neuroscience 41: 901 - 910 [IF 6.7] PDF

  174. Coenjaerts M, Pape F, Santoso V, Grau F, Stoffel-Wagner B, Philipsen A, Schultz J, Hurlemann R, Scheele D (2021) Sex differences in economic decision-making: exogenous estradiol has opposing effects on fairness framing in women and men. European Neuropsychopharmacology 50: 46 - 54 [IF 5.4] Link

  175. Marsh N, Scheele D, Posten D, Onken M, Hurlemann R (2021) Eye-tracking reveals a role of oxytocin in attention allocation towards familiar faces. Frontiers in Endocrinology 12: 629760 [IF 6.0] PDF

  176. Lehmann M, Neumann C, Wasserthal S, Schultz J, Delis A, Trautner P, Hurlemann R, Ettinger U (2021) Effects of ketamine on brain function during metacognition of episodic memory. Neuroscience of Consciousness 7: niaa028 [IF 4.1] PDF

  177. Fassbender K, Bey K, Lippold JV, Aslan B, Hurlemann R, Ettinger U (2021) GABAergic modulation of performance in response inhibition and interference control tasks. Journal of Psychopharmacology 35: 1496 - 1509 [IF 4.6] PDF

  178. Morr M, Lieberz J, Dobbelstein M, Philipsen A, Hurlemann R, Scheele D (2021) Insula reactivity mediates subjective isolation stress in alexithymia. Scientific Reports 11:15326 [IF 5.0] PDF

  179. Doppelhofer LM, Hurlemann R, Bach DR, Korn CW (2021) Social motives in a patient with bilateral selective amygdala lesions: Shift in prosocial motivation but not in social value orientation. Neuropsychologia 162: 108016 [IF 3.1] Link

  180. Lieberz J, Shamay-Tsoory SG, Saporta N, Esser T, Kuskova E, Stoffel-Wagner B, Hurlemann R, Scheele D (2021) Loneliness and the social brain: how perceived social isolation impairs human interactions. Advanced Science 8: e2102076 [IF 17.5] PDF

  181. Saporta N, Scheele D, Hurlemann R, Lieberz J, Stuhr-Wulff F, Shamay-Tsoory SG (2021) Opposing association of situational and chronic loneliness with interpersonal distance. Brain Sciences 11: 1135 [IF 3.3] PDF

  182. Hebel T, Grözinger M, Landgrebe M, Padberg F, Schecklmann M, Schlaepfer T, Schönfeldt-Lecuona C, Ullrich H, Zwanzger P, Langguth B; And the DGHP Consensus Group, Bajbouj M, Bewernick B, Brinkmann K, Cordes J, Di Pauli J, Eichhammer P, Freundlieb N, Hajak G, Höppner-Buchmann J, Hurlemann R, Kamp D, Kayser S, Kis B, Kreuzer PM, Kuhn J, Lammers M, Lugmayer B, Mielacher C, Nickl-Jockschat T, Nunhofer C, Palm U, Poeppl TB, Polak T, Sakreida K, Sartorius A, Silberbauer C, Zilles-Wegner D (2022) Evidence and expert consensus based German guidelines for the use of repetitive transcranial magnetic stimulation in depression. The World Journal of Biological Psychiatry 23: 327 - 348 [IF 3.1] Link

  183. Saporta N, Peled-Avron L, Scheele D, Lieberz J‚ Hurlemann R, Shamay-Tsoory SG (2022) Touched by loneliness – How loneliness impacts the response to observed human touch: a tDCS study. Social Cognitive & Affective Neuroscience (SCAN) 17: 142 - 150 [IF 4.2] PDF

  184. Lieberz J‚ Shamay-Tsoory SG, Saporta N, Kanterman A, Gorni J, Esser T, Kuskova E, Schultz J, Hurlemann R, Scheele D (2022) Behavioral and neural dissociation of social anxiety and loneliness.
 The Journal of Neuroscience 42: 2570 - 2583 [IF 5.3] PDF

  185. Saporta N, Scheele D, Lieberz J‚ Nevat M, Kanterman A, Hurlemann R, Shamay-Tsoory SG (2022) Altered activation in the action observation system during synchronization in high loneliness individuals.
 Cerebral Cortex 33: 385 - 402 [IF 3.7] Link

  186. Morr M, Noell J, Sassin D, Daniels J, Philipsen A, Becker B, Stoffel-Wagner B, Hurlemann R, Scheele D (2022) Lonely in the dark: Trauma memory and sex-specific dysregulation of amygdala reactivity to fear signals. Advanced Science 9: e2105336 [IF 15.1] PDF

  187. Morr M, Liu X, Hurlemann R, Becker B, Scheele D (2022) Chronic loneliness: Neurocognitive mechanisms and interventions. Psychotherapy & Psychosomatics 2: 1 - 11 [IF 22.8] PDF

  188. Lehmann M, Neumann C, Wasserthal S, Delis A, Schultz J, Hurlemann R, Ettinger U (2022) Ketamine increases fronto-posterior functional connectivity during meta-perceptual confidence ratings. Behavioural Brain Research 430: 113925 [IF 2.7] PDF

  189. Haier J, Beller J, Adorjan K, Bleich S, De Greck M, Griesinger F, Hein A, Hurlemann R, Mees ST, Philipsen A, Rohde G, Schilling G, Trautmann K, Combs SE, Geyer S, Schäfers J (2022) Decision conflicts in clinical care during COVID-19: A patient perspective. Healthcare (Basel) 10: 1019 [IF 2.8] PDF

  190. Wölwer W, Frommann N, Lowe A, Kamp D, Weide K, Bechdolf A, Brockhaus-Dumke A, Hurlemann R, Muthesius A, Klingberg S, Hellmich M, Schmied S, Meyer-Lindenberg A; ISST study group (2022) Efficacy of integrated social cognitive remediation vs. neurocognitive remediation in improving functional outcome in schizophrenia: Concept and design of a multicenter, single-blind RCT (the ISST study). Frontiers in Psychiatry 13: 909370 [IF 4.7] PDF

  191. Kricheldorff J, Kiebs M, Göke K, Kasten FH, Herrmann CS, Witt K, Hurlemann R (2022) Evidence of neuroplastic changes after transcranial magnetic, electric and deep brain stimulation. Brain Sciences 12: 929 [IF 3.3] PDF

  192. Haier J, Beller J, Adorjan K, Bleich S, de Greck M, Griesinger F, Heppt MV, Hurlemann R, Mees ST, Philipsen A, Rohde G, Schilling G, Trautmann K, Combs SE, Geyer S, Schaefers J (2022) Differences in stakeholders' perception of the impact of COVID-19 on clinical care and decision-making. Cancers (Basel) 14: 4317 [IF 5.2] PDF

  193. Haier J, Beller J, Adorjan K, Bleich S, de Greck M, Griesinger F, Heppt M, Hurlemann R, Mees ST, Philipsen A, Rohde G, Schilling G, Trautmann K, Combs SE, Geyer S, Schaefers J.(2022) Decision conflicts in clinical care during COVID-19: A multi-perspective inquiry. Healthcare (Basel) 10: 1914 [IF 2.8] PDF

  194. König A, Müller P, Tröger J, Lindsay H, Alexandersson J, Hinze J, Riemenschneider M, Postin D, Ettore E, Lecomte A, Musiol M, Amblard M, Bremond F, Balazia M, Hurlemann R (2022) Multimodal phenotyping of psychiatric disorders from social interaction: Protocol of a clinical multicenter prospective study. Personalized Medicine in Psychiatry 33: 100094 [IF n.a.] PDF

  195. Schröder R, Faiola E, Urquijo MF, Bey K, Meyhöfer I, Steffens M, Kasparbauer AM, Ruef A, Högenauer H, Hurlemann R, Kambeitz J, Philipsen A, Wagner M, Koutsouleris N, Ettinger U (2022) Neural correlates of smooth pursuit eye movements in schizotypy and recent onset psychosis: a multivariate pattern classification approach. Schizophrenia Bulletin Open 3: sgac034 [IF n.a.] PDF

  196. Coenjaerts M, Trimborn I, Adrovic B, Stoffel-Wagner B, Cahill L, Philipsen A, Hurlemann R, Scheele D (2022) Exogenous estradiol and oxytocin modulate sex differences in hippocampal reactivity during the encoding of episodic memories. Neuroimage 264: 119689 [IF 5.7] PDF

  197. Coenjaerts M, Adrovic B, Trimborn I, Philipsen A, Hurlemann R, Scheele D (2023) Effects of exogenous oxytocin and estradiol on resting-state functional connectivity in women and men. Scientific Reports 13: 3113 [IF 4.6*] PDF

  198. Heinz A, Meyer-Lindenberg A, DGPPN Taskforce “Klima und Psyche” (2023) Klimawandel und psychische Gesundheit. Positionspapier einer Task-Force der DGPPN. Der Nervenarzt 94: 225 - 233 (article in German) [IF 1.1*] PDF

  199. Hurlemann R (2023) Pharmakologische Therapiestrategien bei Exazerbation oder Rezidiv einer Schizophrenie. MedLearning CME article (article in German) [IF n.a.] Link

  200. Ettore E, Müller P, Hinze J, Riemenschneider M, Benoit M, Giordana B, Postin D, Hurlemann R, Lecomte A, Musiol M, Lindsay H, Robert P, König A (2023) Digital phenotyping for differential diagnosis of major depressive episode: Narrative review. JMIR Mental Health 10: e46831 [IF 5.2*] PDF

  201. Swed S, Bohsas H, Alibrahim H, Rakab A, Hafez W, Sawaf B, Amir RM, Motawei AS, Aljabali A, Shoib S, Atef Ismail Ahmed Ibrahim I, Ahmad Almashaqbeh SH, Qaid Shaddad EA, Alqaisi M, Abdelrahman A, Fathey S, Hurlemann R, Elsayed MEG, Barboza JJ, Mohanty A, Rodriguez-Morales AJ, Padhi BK, Sah R (2023) Monkeypox post-COVID-19: Knowledge, worrying, and vaccine adoption in the arabic general population. Vaccines (Basel)11: 759 [IF 7.8*] PDF

  202. Ascone L, Rohenkohl AC, Hurlemann R, Meisenzahl E, Riedel-Heller SG, Becker T, Bajbouj M, von Lilienfeld-Toal M, Gallinat J, Lambert M (2023) Erfassung direkter (COVID-19-bezogener) und kollateraler, psychosozialer Folgen für vulnerable Gruppen am Beispiel schwerer psychischer Erkrankungen. Psychiatrische Praxis 50: 381 - 388 (article in German) [IF 2.2*] PDF

  203. Schuster T, Lowe A, Weide K, Kamp D, Riesbeck M, Bechdolf A, Brockhaus-Dumke A, Hurlemann R, Muthesius A, Klingberg S, Hellmich M, Schmied S, Meyer-Lindenberg A, Wölwer W; ISST study group (2023) Feasibility of six-month outpatient cognitive remediation in schizophrenia: Experience from the randomized controlled integrated social cognition and social skills therapy study. Schizophrenia Research: Cognition 33: 100285 [IF 2.8*] PDF

  204. Khaity A, Mostafa Al-Dardery N, Albakri K, Abdelwahab OA, Hefnawy MT, Yousef YAS, Taha RE, Swed S, Hafez W, Hurlemann R, Elsayed MEG (2023) Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis. Frontiers in Psychiatry 14: 1153648 [IF 4.7*] PDF

  205. Swed S, Alibrahim H, Bohsas H, Jawish N, Rais MA, Nasif MN, Hafez W, Sawaf B, Abdelrahman A, Fathey S, Atef Ismail Ahmed Ibrahim I, Almashaqbeh SHA, Yousef Aljawarneh RM, Rakab A, El-Shafei EHH, Hurlemann R, Elsayed MEG, Data Collection Group (2023) A multinational cross-sectional study on the awareness and concerns of healthcare providers toward monkeypox and the promotion of the monkeypox vaccination. Frontiers in Public Health 11: 1153136 [IF 5.2*] PDF

  206. Schneider E, Hopf D, Aguilar-Raab C, Scheele D, Neubauer AB, Sailer U, Hurlemann R, Eckstein M, Ditzen B (2023) Affectionate touch and diurnal oxytocin levels: An ecological momentary assessment study. Elife 12: e81241 [IF 7.7*] PDF

  207. Assion HJ, Aubel T, Hajak G, Heres S, Hurlemann R, Kühn KU, Leopold K, Rujescu D, Vasic N, Wobrock T, Leucht S (2023) Risperidon ISM®: Innovative Depotformulierung zur Therapie der Schizophrenie. Psychopharmakotherapie 30: 72 - 81 (article in German) [IF n.a.] Link

  208. Steinhäuser JL, Teed AR, Al-Zoubi O, Hurlemann R, Chen G, Khalsa SS (2023) Reduced vmPFC-insula functional connectivity in generalized anxiety disorder: a Bayesian confirmation study. Scientific Reports 13: 9626 [IF 5.0*] PDF

  209. Abivardi A, Korn CW, Rojkov I, Gerster S, Hurlemann R, Bach DR (2023) Acceleration of inferred neural responses to oddball targets in an individual with bilateral amygdala lesion compared to healthy controls. Scientific Reports 13: 14550 [IF 5.0*] PDF

  210. Wasserthal S, Lehmann M, Neumann C, Delis A, Philipsen A, Hurlemann R, Ettinger U, Schultz J (2023) Effects of NMDA-receptor blockade by ketamine on mentalizing and its neural correlates in humans: a randomized control trial. Scientific Reports 13: 17184 [IF 5.0*] PDF

  211. Mueller JK, Ahrens KF, Bauer M, Baune BT, Borgwardt S, Deckert J, Domschke K, Ellwanger R, Fallgatter A, Frodl T, Gallinat J, Gottschalk R, Grabe HJ, Hasan A, Herpertz SC, Hurlemann R, Jessen F, Kambeitz J, Kircher T, Kornhuber J, Lieb K, Meyer-Lindenberg A, Rupprecht R, Scherbaum N, Schlang C, Schneider A, Schomerus G, Thoma A, Unterecker S, Walter M, Walter H, Reif A, Reif-Leonhard C (2023) Prevalence of COVID-19 and psychotropic drug treatment in psychiatric in-patients in Germany in 2020: Results from a nationwide pilot survey. Pharmacopsychiatry 56: 227 - 238 [IF 4.3*] PDF

  212. Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg A, Kessler U, Sartorius A, Dols A, Narr K, Espinoza R, Van Waarde J, Tendolkar I, van Eijndhoven P, van Wingen G, Takamiya A, Kishimoto T, Jorgensen M, Jorgensen A, Paulson O, Yrondi A, Peran P, Soriano-Mas C, Cardoner N, Cano M, van Diermen L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders P, Redlich R, Dannlowski U, Kavakbasi E, Kritzer M, Ellard K, Camprodon J, Petrides G, Maholtra A, Abbott C (2024) Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression. Molecular Psychiatry (in press) [IF 11.0*] PDF

  213. Mielacher C, Scheele D, Kiebs M, Schmitt L, Dellert T, Philipsen A, Lamm C, Hurlemann R (2024) Altered reward network responses to social touch in major depression. Psychological Medicine 54: 308 - 316 [IF 6.9*] PDF

  214. Baune BT, Fromme SE, Kiebs M, Hurlemann R (2024) Clinical management of treatment-resistant depression. Nervenarzt 95: 416 - 422 (article in German) [IF 1.1*] PDF

  215. Hurlemann R & Domschke K (2024) Challenging treatment resistance. Nervenarzt 95: 405 - 406 (article in German) [IF 1.1*] PDF

  216. Berger R, Hurlemann R, Shamay-Tsoory S, Kanterman A, Brauser M, Gorni J, Luhmann M, Schramm E, Schultz J, Philipsen A, Lieberz J, Scheele D (2024) Oxytocin-augmented modular-based group intervention for loneliness: A proof-of-concept randomized-controlled trial. Psychotherapy & Psychosomatics (in press) [IF 22.8*]

  217. Barton S, Zovko A, Mueller C, Krabichler Q, Schulze J, Wagner S, Grinevich V, Shamay- Tsoory S, Hurlemann R (2024) A translational neuroscience perspective on loneliness: Narrative review focusing on social interaction, illness and oxytocin. Neuroscience & Biobehavioral Reviews (in press) [IF 8.2*]

Abbreviations: AS, Article Altmetric Score; IF, Journal Impact Factor; *, latest impact factor reported by Clarivate